Research on Establishment of Abnormal Phlegmatic Syndrome with Premature Ovarian Failure Rat Model and Effects of Balgham Munziq Treatment

Evidence-based Complementary and Alternative Medicine : ECAM
Muladili YuemaierXiamixinuer Yilike

Abstract

This study aimed to establish and explore the biological basis of abnormal phlegmatic syndrome with premature ovarian failure (POF) model in rats based on the Uighur medicine (UM) in the first place and investigate the effects of unique herbal medicine, Balgham Munziq (BMq). Mature female Wistar rats were fed with spinach and coriander in cold and humid condition for approximately 20 weeks until abnormal phlegmatic syndrome (APS) model was established. When APS model was confirmed by Uighur medical experts, APS with POF disease rats were subdivided into APS with POF disease model group and APS with POF disease treated with BMq group; the rest of them were subdivided into APS model group and APS treated with BMq group. The results show that biological characteristics of animals in the course of modeling period were in accordance with clinical features of abnormal phlegmatic syndrome (APS) in Uighur medicine. Herbal medicine BMq not only reverted reproductive hormone levels disorders but also improved the function of hypothalamic-pituitary-ovarian axis and regulated secretion of monoamine neurotransmitters. APS is most likely to cause pathological changes of hypothalamic-pituitary-ovarian axis and lead to the occurrence of POF an...Continue Reading

References

Oct 19, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shannon Reagan-ShawNihal Ahmad
Apr 12, 2008·Pituitary·Micol S Rothman, Margaret E Wierman
Mar 27, 2010·Neuroscience and Behavioral Physiology·E E FomichevaE G Rybakina
Dec 26, 2012·Animal Reproduction Science·Dong LiGuoyun Wang
Dec 29, 2013·Psychopharmacology·Andrew R Burke, Klaus A Miczek
Oct 16, 2014·Journal of the Turkish German Gynecological Association·Yavuz Emre SükürBatuhan Ozmen
Feb 16, 2015·Obstetrics and Gynecology Clinics of North America·Ertug Kovanci, Amy K Schutt
Feb 16, 2015·Reproductive Biomedicine Online·Huidan WangZi-Jiang Chen
Apr 8, 2015·Climacteric : the Journal of the International Menopause Society·S S FaubionW A Rocca
Oct 9, 2015·International Journal of Women's Health·Chevy ChapmanAndrew N Shelling
Oct 16, 2015·Journal of Assisted Reproduction and Genetics·J CohenE Darai
Oct 27, 2015·Journal of Inherited Metabolic Disease·Jessie C JacobsenKlaus Lehnert
Feb 24, 2016·Journal of Mid-life Health·Anna J Fenton
Apr 21, 2016·Przegla̜d menopauzalny = Menopause review·Anna CyganekBarbara Grzechocińska
Oct 30, 2016·Regulatory Toxicology and Pharmacology : RTP·Ting ZhangZuyue Sun

❮ Previous
Next ❯

Methods Mentioned

BETA
hormone replacement therapy
enzyme-linked
ELISA

Software Mentioned

SPSS

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Related Papers

Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Chun-rong QinYan-qun Luo
Clinics in Endocrinology and Metabolism
D T Baird, I S Fraser
Menopause : the Journal of the North American Menopause Society
Ibrahim GulhanErbil Dogan
Menopause : the Journal of the North American Menopause Society
Deborah Marçal Bueno de AlmeidaMaria Yolanda Makuch
© 2022 Meta ULC. All rights reserved